-
Mashup Score: 5Multidisciplinary Tumor Board - Unraveling the Challenges: Comprehensive Approach to Management of CNS Metastases in Breast Cancer - 7 month(s) ago
Memorial Sloan Kettering Cancer Center (MSK) in New York proudly presents educational programs for current and future physicians and scientists. Through this interactive series, we look to accelerate the exchange of knowledge to improve patient outcomes, foster new research collaborations, and increase graduate and post-graduate training exchange. The focus of our next event will be on the management of oligoprogression in breast cancer. Wednesday, 11 October, 2023 6:00-7:30 p.m. IST | 8:30-10:00 a.m. US
Source: c.mskinfo.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Breast milk from people with overweight/obesity may differ in composition compared with that from normal-weight people. Exercise training can modify breast milk composition in rodent models, with a beneficial impact demonstrated on the offspring’s metabolism, but whether these findings translate to humans is unclear. This trial aims to determine the effect of an exercise intervention on breast milk composition and whether an exercise-induced modification of breast milk impacts the infants’ growth and body composition. Effect of Exercise Training on Breastmilk Composition is a randomised, controlled trial with two parallel groups, one exercise group and one control group, with a 1:1 allocation. We will include a minimum of 62 exclusively breastfeeding participants, 6 weeks postpartum. The exercise intervention lasts 8 weeks and comprises 25 supervised endurance exercise sessions with moderate or high intensity. The primary outcome measure is the change in the relative concentration of t
Source: bmjopensem.bmj.comCategories: Latest Headlines, OrthopedicsTweet
-
Mashup Score: 0Breast Cancer Program - 7 month(s) ago
The breast cancer program at Johns Hopkins is made up of a diverse group of nationally-recognized specialists in breast cancer research and treatment. Led by Vered Stearns, M.D., and Sara Sukumar, Ph.D, physician-scientists in the breast cancer program.
Source: www.hopkinsmedicine.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0What New Moms Need To Know About Pumping Breastmilk At Work - 7 month(s) ago
Wondering how to talk to your employer about pumping at work? We have tips for approaching the subject and for making pumping at work easier.
Source: www.henryford.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0Missing mammograms: Over 20% of women don’t follow breast cancer screening guidelines, study says - 7 month(s) ago
A new report has found that 21.7% of U.S. women aged 50 to 74 — around one in five — are not getting mammogram screenings at the recommended frequency. Doctors share risks and benefits.
Source: www.foxnews.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
OVERVIEWThis educational activity will provide participants with an overview of the most up-to-date research and clinical advances in treating various oncologic malignancies based on abstracts presented at the 2023 annual American Society of Clinical Oncology (ASCO) meeting. Featured topics and case presentations will cover lung cancer, breast cancer, gastrointestinal cancers, genitourinary…
Source: event.onclive.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 3MD Anderson Research Highlights for August 2, 2023 - 9 month(s) ago
Recent developments include a novel biomarker for early detection of gastric differentiation in precursors of pancreatic cancer, further insights into the structure and function of a breast and ovarian cancer susceptibility gene, a novel approach for overcoming treatment resistance in ovarian cancer, insights into the rise of young-onset rectal cancer, an epigenetic prognostic biomarker and potential target for metastatic lung cancer, machine learning models to better predict outcomes of patients with mantle cell lymphoma (MCL), and a promising therapy for patients with relapsed/refractory MCL.
Source: www.mdanderson.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 4SurgOnc Today® - 9 month(s) ago
SurgOnc Today® is an educational podcast for cancer surgeons from the Society of Surgical Oncology. Each episode features conversations with individuals who are experts within their respective fields and are members of SSO. Listen to the most recent episodes below or find all of the SurgOnc Today® episodes, organized by disease site, on ExpertEd@SSO and in the … SurgOnc Today® Read More »
Source: www.surgonc.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
📣 Contemplating a career as a surgical oncologist? Then this episode of SurgOnc Today® is for you! 🎙️ @adwilliams5, @DrZacharyJBrown & @globalsurgallie discuss #surgicaloncology career options, including #breast, #hepatobiliary & #colorectal Listen now: https://t.co/ehFdXjMlcT https://t.co/fSx7Q9Zl1U
-
-
Mashup Score: 40The OncoAlert Newsletter is NOW OUT Click to Register - 10 month(s) ago
The OncoAlert Newsletter is now out for June 23-29, 2023
Source: www.OncoAlert360.comCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @OncoAlert: The @oncoAlert 🚨Newsletter OUT TOMORROW: July 27, 2023 REGISTER📨to get it https://t.co/yzt83gqQkF Discussing: ✅DAISY🌼i…
-
The @oncoAlert 🚨Newsletter OUT TOMORROW: July 27, 2023 REGISTER📨to get it https://t.co/yzt83gqQkF Discussing: ✅DAISY🌼in #BreastCancer from @FAndreMD 🇫🇷 ✅RLY-4008 out on @CD_AACR by @VivekSubbiah 🇺🇸 ✅Obesity changes in #Breast Cancer from @ChristineDesme2 🇧🇪 ✅CA19-9… https://t.co/FbQ21kxRm9 https://t.co/T4ze548yRj
-
-
Mashup Score: 0RAGE inhibitor TTP488 (Azeliragon) suppresses metastasis in triple-negative breast cancer - npj Breast Cancer - 10 month(s) ago
Triple-negative breast cancer (TNBC) is a highly aggressive and metastatic cancer subtype, which is generally untreatable once it metastasizes. We hypothesized that interfering with the Receptor for Advanced Glycation End-products (RAGE) signaling with the small molecule RAGE inhibitors (TTP488/Azeliragon and FPS-ZM1) would impair TNBC metastasis and impair fundamental mechanisms underlying tumor…
Source: NatureCategories: General Medicine News, Latest HeadlinesTweet
On 10/11, @MSKCancerCenter & @aiims_newdelhi will launch a virtual tumor board series on #breast cancers. Join us in fighting cancer through patient care, education, research, & advocacy. Register here: https://t.co/0KlFMSnXJk #BCAM #tumorboard https://t.co/bM071hqR27